Trial to test Lymphoseek in patients with colorectal cancer

02/4/2013 | AuntMinnie.com (free registration)

Navidea Biopharmaceuticals has formed a partnership with Maimonides Medical Center in New York that will focus on an open-label clinical trial involving Lymphoseek, a radiopharmaceutical designed to stage cancers by pinpointing the lymph nodes that drain from a primary tumor. The trial will test the agent in patients with colorectal cancer and is set to start in the first half of the year.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ